Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. - Test2 - elhamkhani - TriplyDB

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

http://www.wikidata.org/entity/Q35534065

about

Regular treatment with salmeterol for chronic asthma: serious adverse events Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid Long-acting beta2-agonists for stable chronic asthma A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulation Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms.Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.Notes on testing equality and interval estimation in Poisson frequency data under a three-treatment three-period crossover trial.What is new with the beta2-agonists: issues in the management of asthma.ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients Predicting response to short-acting bronchodilator medication using Bayesian networks.The role of pharmacogenomics in improving the management of asthma A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged high-throughput biophysical screening Asthma in sickle cell disease: implications for treatment.Pharmacogenomic approaches to asthma treatment.Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.The relative power of SNPs and haplotype as genetic markers for association tests.Genetic polymorphisms and associated susceptibility to asthma.Severe asthma: definition and mechanisms.Long-acting inhaled beta(2)-agonist therapy in asthma.Special considerations for adolescent athletic and asthmatic patients.Pharmacogenomics of pediatric asthma.Recent developments in the genetics of asthma.Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction.Beta-adrenergic receptor polymorphisms and drug responses in asthma.Beta-agonist intrinsic efficacy: measurement and clinical significance.Can certain genotypes predispose to poor asthma control in children? A pharmacogenetic study of 9 candidate genes in children with difficult asthma.Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma Antagonism of long-acting beta2-adrenoceptor agonism.Asthma pharmacogenetics and the development of genetic profiles for personalized medicine Beta2 adrenergic receptor (ADRβ2) haplotype pair (2/4) is associated with severe asthma Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to β2-agonist Treatment.Evaluation of spirometry values in relation to beta-2-adrenergic receptor gene polymorphism.Beta-agonists and asthma: too much of a good thing?Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol Acute severe asthma.Genetics of allergic diseases.Pharmacogenomics of long-acting β2-agonists.Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype

P2860

Q24241960-C02DB2C4-732B-413A-8F7D-3140D115B146 Q24246441-2ED3AF0D-DD3B-415A-920A-7D5C1A23F564 Q24247926-3F39769A-3C38-43C6-B69A-CA228EA0B7F9 Q28258154-26FF561D-0CB3-45E9-B55C-BFD6E1F5C968 Q28481005-BF1E2423-B011-40C6-B0DF-F7B8AD09F9A3 Q30413107-8AAF3C24-0719-48B3-B747-70275E341677 Q30444397-9FBBDB45-243E-4417-8CED-63FEA885D1BF Q30736948-5BE47C3D-1860-4F05-BFAC-C398B4C8185F Q33213762-423B5CC7-3D15-4555-8975-19D7FE71335B Q33278280-1E548592-20B0-445D-A63B-567F2E42976C Q33580289-C642B253-3551-4CFD-A13D-FC69E362401D Q33581533-50DEABAE-4611-4CEA-8626-90CD4FA2FB79 Q33669054-2327522B-0B0B-4DDC-A8BD-1376A92D221C Q33792594-36BB5C40-4BE2-4331-BE1F-5DA6DD6F5EB4 Q33872120-02ED7F33-3A2E-4CEE-9103-AE29ACF203B9 Q33940766-B39B5FF3-2ADD-4FB4-A68C-A3B77093AF4C Q34038869-AE74FE62-7DAA-4FE3-9390-DD8150DEBE4C Q34189626-DF16781C-89E3-48B8-B839-FD80AEACB60D Q34342451-0D2ACE99-956A-4070-A3F3-A692F9289269 Q34364866-9680789A-3025-4774-82CF-2B0256FF7492 Q34392656-60CAAFF6-4490-44E4-9C33-F251AB16A0A2 Q34394995-5F8C76A8-905A-43CB-A885-4732DCC13013 Q34436523-97C10039-70A0-44A6-B6BD-1172F0C29033 Q34448286-105A711D-B5EA-46C9-9AE1-D69682BF5ED8 Q34606153-C8391F67-12C9-421F-8F4A-E6F9F13A31B2 Q34612106-B6CEDF99-6514-4351-9F47-A1AF27F1917C Q34642515-690C6563-C59D-49FD-9CCD-2E790D0BE18F Q34662042-1814BEFD-4012-49DD-B87B-2C3078D74C12 Q34698968-7F308BD6-553F-4998-8FB1-15E43B590048 Q34866359-79E75C0E-AEDD-4C5D-8932-3552508187BB Q35076452-805B0CA2-4577-4E21-A406-6137051E2854 Q35137713-0FFCF291-12B1-453F-AE88-FDEBBC247328 Q35157970-C1797E50-FBD7-48B5-87FC-8E56F286DC98 Q35179106-5A43B4ED-8C2E-409D-81A0-1E9764444A30 Q35202472-D553D030-1669-4D43-9859-E879845A074C Q35536841-48B801DA-0041-4F9B-A3AE-25BA36E1EC75 Q35548946-10D62AC6-218D-4447-894C-CF2C5231CCEE Q35556785-5DB4AE42-0A4F-4A00-8007-EE954B7F9D14 Q35734012-5DB52A9B-2D28-4078-9C29-63487241A730 Q35825639-4EF9CD5B-A0E6-44F8-BE36-7097710F3643

P2860

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

http://www.wikidata.org/entity/Q35534065

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@ast

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@en

type

label

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@ast

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@en

prefLabel

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@ast

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@en

P1433

Q35534065-A6423AF6-B89F-48B5-ADEA-268B1502F60C

P1476

Q35534065-EB44C03D-D200-4F6A-BFC2-15D08325DF3E

P2093

Q35534065-1691405C-7FB8-47BE-91DC-AC8DCBA5E7BD

Q35534065-18619E47-E640-4196-B5C4-0A78D0AC16F0

Q35534065-2AA225B5-DB5E-476F-BAED-7D8A0C027D83

Q35534065-310C63E9-FFC7-4434-8E47-63AFBAD511FB

Q35534065-3A434F49-591F-495A-87CD-B442C49957D9

Q35534065-ED3CCFAD-B31F-4F35-B63F-D89B6B83963A

P2860

Q35534065-0177A7DB-0E1F-44BA-9249-C4822E5CCEFE

Q35534065-0BCE72C9-4E09-428E-9C08-A0DFA0905DF6

Q35534065-27AC020B-0882-4C5E-A6D0-72B4BC5E079E

Q35534065-292A8F95-A931-4092-8D80-AC8DE4AE8D1E

Q35534065-422F93D6-7130-46B8-BD25-6702552954CB

Q35534065-862C8293-282D-449F-9C94-A274742F8813

Q35534065-B0A7651F-2DD8-49D2-A585-ACB43583274F

Q35534065-B1E82DC7-E52C-40EF-A432-4B40C9CB81D4

Q35534065-D70DAB84-04BB-467A-821D-312072EA2C56

Q35534065-DFED5387-DF3A-4E50-91A9-8C03B3CD0256

P304

Q35534065-486CA2D8-F530-40F7-A218-202FEF7FAE4F

P31

Q35534065-08CDCE1A-38C6-41D9-9407-7F29CE74BC2E

P356

Q35534065-CBD3FC84-F74E-4283-9931-F209BF5DFC01

P407

Q35534065-33F71744-6EA8-41B7-9376-20FBAB334500

P433

Q35534065-E23DD40A-8819-4444-AFA0-32BC04269DB7

P478

Q35534065-A9700EF2-DB2D-42DD-B777-FB9DE0CD3F0F

P577

Q35534065-7FC5C3E0-96B7-4E13-BBA1-03A01F5E579B

P698

Q35534065-2FDCF5E7-23F6-4E2C-853E-4972D9ED5518

P921

Q35534065-5CB62FCF-495D-49D6-B26A-AD5BBE0612C8

P932

Q35534065-843A1237-6FC5-405E-9B34-270D4D7C7B8C

P356

THORAX.55.9.762

P1433

P1476

Asthma exacerbations during lo ...... (2) adrenoceptor polymorphism.

@en

P2093

Drazen JM

http://www.w3.org/2001/XMLSchema#string

Hancox RJ

http://www.w3.org/2001/XMLSchema#string

Herbison GP

http://www.w3.org/2001/XMLSchema#string

Taylor DR

http://www.w3.org/2001/XMLSchema#string

Town GI

http://www.w3.org/2001/XMLSchema#string

Yandava CN

http://www.w3.org/2001/XMLSchema#string

P2860

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

Functional antagonism: tolerance produced by inhaled beta 2 agonists

Beta 2 adrenoceptor polymorphisms: are they clinically important?

Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population.

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.

P304

762-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THORAX.55.9.762

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10950895

http://www.w3.org/2001/XMLSchema#string

P921

P932

1745862

http://www.w3.org/2001/XMLSchema#string